Posts

Guidelines for the Management of Methamphetamine Use Disorders in Myanmar

This Guide conveys practical information as well as covering some theoretical advances to improve insights about the growing concern of methamphetamine use in Myanmar.

Global Hepatitis Report 2017

The report focuses on hepatitis B and C, which are responsible for 96% of all hepatitis mortality. It presents data along the five strategic directions (strategic information, interventions, equity, financing and innovation) – key pillars of the GHSS to facilitate monitoring of progress in countries, regions and globally, and to measure the impact of interventions on reducing new infections and
saving lives between 2015 and 2030.

Global report on access to hepatitis C treatment – Focus on overcoming barriers

This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome.

WHO HCV Guidelines – Updated

WHO updated its hepatitis C treatment guidelines to provide recommendations for the use of these new medicines. The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014.

Summary of generic sofosbuvir availability in India

Summary of generic sofosbuvir availability in India and pricing as of 18 May 2015.

TREAT Asia Fact Sheet

This fact sheet summarizes the major recommendations of WHO first guidelines on screening, care, and treatment of hepatitis C infection.